Search - tctmd.com

Displaying 1 - 20 of 156

Sort: Relevancy | Date

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Daily News

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

L.A. McKeown

February 07, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Yael L. Maxwell

April 03, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

Medtronic Recalls IN.PACT Admiral and IN.PACT AV Catheters

L.A. McKeown

March 31, 2022

Advertisement

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

Top Endovascular News of 2024

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Physicians (Mostly) Negative on Private Equity in Healthcare

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Experts Warn of Looming Private Equity Interest in Cardiology Care

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Top Endovascular News of 2023

High-Sensitivity Troponins May Overestimate PE Severity

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

BP Reduction With Renal Denervation Still Evident a Decade On

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Medtronic Recalls IN.PACT Admiral and IN.PACT AV Catheters

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content